{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:50:22Z","timestamp":1789429822326,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Age-related macular degeneration (AMD) is the predominant cause of vision loss in the elderly with a major impact on ageing societies and healthcare systems. A major challenge in AMD management is the difficulty to determine the disease stage, the highly variable progression speed and the risk of conversion to advanced AMD, where irreversible functional loss occurs. In this study we developed an optical coherence tomography (OCT) imaging based spatio-temporal reference frame to characterize the morphologic progression of intermediate age-related macular degeneration (AMD) and to identify distinctive patterns of conversion to the advanced stages macular neovascularization (MNV) and macular atrophy (MA). We included 10,040 OCT volumes of 518 eyes with intermediate AMD acquired according to a standardized protocol in monthly intervals over two years. Two independent masked retina specialists determined the time of conversion to MNV or MA. All scans were aligned to a common reference frame by intra-patient and inter-patient registration. Automated segmentations of retinal layers and the choroid were computed and en-face maps were transformed into the common reference frame. Population maps were constructed in the subgroups converting to MNV (n=135), MA (n=50) and in non-progressors (n=333). Topographically resolved maps of changes were computed and tested for statistical significant differences. The development over time was analysed by a joint model accounting for longitudinal and right-censoring aspect. Significantly enhanced thinning of the outer nuclear layer (ONL) and retinal pigment epithelium (RPE)\u2013photoreceptorinner segment\/outer segment (PR-IS\/OS) layers within the central 3 mm and a faster thinning speed preceding conversion was documented for MA progressors. Converters to MNV presented an accelerated thinning of the choroid and appearance changes in the choroid prior to MNV onset. The large-scale automated image analysis allowed us to distinctly assess the progression of morphologic changes in intermediate AMD based on conventional OCT imaging. Distinct topographic and temporal patterns allow to prospectively determine eyes with risk of progression and thereby greatly improving early detection, prevention and development of novel therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41598-021-85110-y","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T06:03:49Z","timestamp":1615442629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography"],"prefix":"10.1038","volume":"11","author":[{"given":"Wolf-Dieter","family":"Vogl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Bogunovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.","family":"Waldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"85110_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell, P., Liew, G., Gopinath, B. & Wong, T. Y. Age-related macular degeneration. The Lancet 392, 1147\u20131159. https:\/\/doi.org\/10.1016\/S0140-6736(18)31550-2 (2018).","journal-title":"The Lancet"},{"key":"85110_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106-116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1 (2014).","journal-title":"Lancet Glob. Health"},{"key":"85110_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris, F. L. et al. Clinical classification of age-related macular degeneration. Ophthalmology 120, 844\u2013851. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.036 (2013).","journal-title":"Ophthalmology"},{"key":"85110_CR4","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1167\/iovs.18-24106","volume":"59","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth, U. et al. Prediction of individual disease conversion in early AMD using artificial intelligence. Invest. Ophthalmol. Vis. Sci. 59, 3199\u20133208. https:\/\/doi.org\/10.1167\/iovs.18-24106 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","volume":"50","author":"U Schmidt-Erfurth","year":"2016","unstructured":"Schmidt-Erfurth, U. & Waldstein, S. M. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Progr. Retinal Eye Res. 50, 1\u201324. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.07.007 (2016).","journal-title":"Progr. Retinal Eye Res."},{"key":"85110_CR6","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/S1053-8119(09)70884-5","volume":"47","author":"VS Fonov","year":"2009","unstructured":"Fonov, V. S., Evans, A. C., McKinstry, R. C., Almli, C. R. & Collins, D. L. Unbiased nonlinear average age-appropriate brain templates from birth to adulthood. NeuroImage 47, S102. https:\/\/doi.org\/10.1016\/S1053-8119(09)70884-5 (2009).","journal-title":"NeuroImage"},{"key":"85110_CR7","first-page":"29","volume":"4","author":"H Matsuda","year":"2013","unstructured":"Matsuda, H. Voxel-based morphometry of brain MRI in normal aging and alzheimer\u2019s disease. Aging Dis. 4, 29\u201337 (2013).","journal-title":"Aging Dis."},{"key":"85110_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.media.2016.08.012","volume":"35","author":"S Lee","year":"2017","unstructured":"Lee, S. et al. Atlas-based shape analysis and classification of retinal optical coherence tomography images using the functional shape (fshape) framework. Med. Image Anal. 35, 570\u2013581. https:\/\/doi.org\/10.1016\/j.media.2016.08.012 (2017).","journal-title":"Med. Image Anal."},{"key":"85110_CR9","unstructured":"ClinicalTrials.gov. A study of ranibizumab administered monthly or on an as-needed basis in patients with subfoveal neovascular age-related macular degeneration (HARBOR). NCT00891735. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00891735."},{"key":"85110_CR10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ophtha.2012.10.014","volume":"120","author":"BG Busbee","year":"2013","unstructured":"Busbee, B. G. et al. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 120, 1046\u20131056. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.014 (2013).","journal-title":"Ophthalmology"},{"key":"85110_CR11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ophtha.2014.05.009","volume":"121","author":"AC Ho","year":"2014","unstructured":"Ho, A. C. et al. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 121, 2181\u20132192. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.009 (2014).","journal-title":"Ophthalmology"},{"key":"85110_CR12","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","volume":"121","author":"Z Wu","year":"2014","unstructured":"Wu, Z. et al. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121, 2415\u20132422. https:\/\/doi.org\/10.1016\/j.ophtha.2014.06.034 (2014).","journal-title":"Ophthalmology"},{"key":"85110_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1167\/iovs.15-18572","volume":"57","author":"NS Abdelfattah","year":"2016","unstructured":"Abdelfattah, N. S. et al. Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye. Invest. Ophthalmol. Vis. Sci. 57, 1839\u20131846. https:\/\/doi.org\/10.1167\/iovs.15-18572 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR14","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1109\/TMI.2017.2700213","volume":"36","author":"W-D Vogl","year":"2017","unstructured":"Vogl, W.-D., Waldstein, S. M., Gerendas, B. S., Schmidt-Erfurth, U. & Langs, G. Predicting macular edema recurrence from spatio-temporal signatures in optical coherence tomography images. IEEE Trans. Med. Imaging 36, 1773\u20131783. https:\/\/doi.org\/10.1109\/TMI.2017.2700213 (2017).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"85110_CR15","doi-asserted-by":"crossref","unstructured":"Montuoro, A. et\u00a0al. Motion Artefact Correction in Retinal Optical Coherence Tomography Using Local Symmetry. In Golland, P., Hata, N., Barillot, C., Hornegger, J. & Howe, R. (eds.) Medical Image Computing and Computer-Assisted Intervention\u2014MICCAI 2014: 17th International Conference, Boston, MA, USA, September 14-18, 2014, Proceedings, Part II, 130\u2013137, https:\/\/doi.org\/10.1007\/978-3-319-10470-6_17 (Springer International Publishing, Cham, 2014).","DOI":"10.1007\/978-3-319-10470-6_17"},{"key":"85110_CR16","doi-asserted-by":"crossref","unstructured":"Zuiderveld, K. Contrast Limited Adaptive Histogram Equalization. In Graphics Gems IV, 474\u2013485 (Academic Press Professional Inc (ed. Heckbert, P. S.) (1994).","DOI":"10.1016\/B978-0-12-336156-1.50061-6"},{"key":"85110_CR17","doi-asserted-by":"crossref","unstructured":"Frangi, A.\u00a0F., Niessen, W.\u00a0J., Vincken, K.\u00a0L. & Viergever, M.\u00a0A. Multiscale vessel enhancement filtering. In Wells, W.\u00a0M., Colchester, A. & Delp, S. (eds.) Medical Image Computing and Computer-Assisted Intervention\u2014MICCAI\u201998, Lecture Notes in Computer Science, 130\u2013137 (Springer Berlin Heidelberg, 1998).","DOI":"10.1007\/BFb0056195"},{"key":"85110_CR18","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","volume":"54","author":"BB Avants","year":"2011","unstructured":"Avants, B. B. et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage 54, 2033\u20132044. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.09.025 (2011).","journal-title":"NeuroImage"},{"key":"85110_CR19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1109\/TMI.2009.2016958","volume":"28","author":"MK Garvin","year":"2009","unstructured":"Garvin, M. K. et al. Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images. IEEE Trans. Med. Imaging 28, 1436\u20131447 (2009).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"85110_CR20","first-page":"637","volume":"1981","author":"RC Bolles","year":"1981","unstructured":"Bolles, R. C. & Fischler, M. A. A RANSAC-based approach to model fitting and its application to finding cylinders in range data. IJCAI 1981, 637\u2013643 (1981).","journal-title":"IJCAI"},{"key":"85110_CR21","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1167\/iovs.03-1157","volume":"45","author":"K Rohrschneider","year":"2004","unstructured":"Rohrschneider, K. Determination of the location of the fovea on the fundus. Invest. Ophthalmol. Vis. Sci. 45, 3257\u20133258 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR22","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1167\/iovs.14-15669","volume":"56","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Validity of automated choroidal segmentation in SS-OCT and SD-OCT. Invest. Ophthalmol. Vis. Sci. 56, 3202\u20133211. https:\/\/doi.org\/10.1167\/iovs.14-15669 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR23","doi-asserted-by":"publisher","first-page":"BIO141","DOI":"10.1167\/iovs.17-21789","volume":"58","author":"H Bogunovi\u0107","year":"2017","unstructured":"Bogunovi\u0107, H. et al. Machine learning of the progression of intermediate age-related macular degeneration based on OCT ImagingMachine learning of the progression of AMD based on OCT. Invest. Ophthalmol. Vis. Sci. 58, BIO141\u2013BIO150. https:\/\/doi.org\/10.1167\/iovs.17-21789 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures they are data. Radiology 278, 563\u2013577. https:\/\/doi.org\/10.1148\/radiol.2015151169 (2016).","journal-title":"Radiology"},{"key":"85110_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1109\/PROC.1979.11328","volume":"67","author":"RM Haralick","year":"1979","unstructured":"Haralick, R. M. Statistical and structural approaches to texture. Proc. IEEE 67, 786\u2013804. https:\/\/doi.org\/10.1109\/PROC.1979.11328 (1979).","journal-title":"Proc. IEEE"},{"key":"85110_CR26","unstructured":"Johnson, H. .\u00a0J., McCormick, M. .\u00a0M. & Ibanez, L. Template:The ITK Software Guide Book 1: Introduction and Development Guidelines-Volume 1 4th edn. (Kitware, Inc., 2015)."},{"key":"85110_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"85110_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/biostatistics\/1.4.465","volume":"1","author":"R Henderson","year":"2000","unstructured":"Henderson, R., Diggle, P. & Dobson, A. Joint modelling of longitudinal measurements and event time data. Biostatistics 1, 465\u2013480. https:\/\/doi.org\/10.1093\/biostatistics\/1.4.465 (2000).","journal-title":"Biostatistics"},{"key":"85110_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v072.i07","volume":"72","author":"D Rizopoulos","year":"2016","unstructured":"Rizopoulos, D. The R package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC. J. Stat. Softw. 72, 1\u201346. https:\/\/doi.org\/10.18637\/jss.v072.i07 (2016).","journal-title":"J. Stat. Softw."},{"key":"85110_CR30","unstructured":"Plummer, M. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. In Proceedings of the 3rd International Workshop on Distributed Statistical Computing, vol. 124 (Vienna, Austria., 2003)."},{"key":"85110_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1167\/iovs.18-25332","volume":"60","author":"C Brandl","year":"2019","unstructured":"Brandl, C. et al. Retinal layer thicknesses in early age-related macular degeneration: results from the German AugUR Study. Invest. Ophthalmol. Vis. Sci. 60, 1581\u20131594. https:\/\/doi.org\/10.1167\/iovs.18-25332 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/bjophthalmol-2016-308422","volume":"101","author":"FG Schlanitz","year":"2017","unstructured":"Schlanitz, F. G. et al. Drusen volume development over time and its relevance to the course of age-related macular degeneration. Br. J. Ophthalmol. 101, 198\u2013203. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308422 (2017).","journal-title":"Br. J. Ophthalmol."},{"key":"85110_CR33","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/IAE.0000000000002182","volume":"38","author":"M Li","year":"2018","unstructured":"Li, M. et al. Histology of geographic atrophy secondary to age-related macular degeneration: a multilayer approach. Retina 38, 1937\u20131953. https:\/\/doi.org\/10.1097\/IAE.0000000000002182 (2018).","journal-title":"Retina"},{"key":"85110_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1167\/iovs.12-11286","volume":"54","author":"S Sadigh","year":"2013","unstructured":"Sadigh, S. et al. Abnormal thickening as well as thinning of the photoreceptor layer in intermediate age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54, 1603\u20131612. https:\/\/doi.org\/10.1167\/iovs.12-11286 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR35","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/IAE.0000000000000527","volume":"35","author":"BJ Lujan","year":"2015","unstructured":"Lujan, B. J. et al. Directional optical coherence tomography provides accurate outer nuclear layer and henle fiber layer measurements. Retina 35, 1511\u20131520. https:\/\/doi.org\/10.1097\/IAE.0000000000000527 (2015).","journal-title":"Retina"},{"key":"85110_CR36","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ajo.2015.05.030","volume":"160","author":"I Zucchiatti","year":"2015","unstructured":"Zucchiatti, I. et al. Macular ganglion cell complex and retinal nerve fiber layer comparison in different stages of age-related macular degeneration. Am. J. Ophthalmol. 160, 602-607.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.05.030 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"85110_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.06.005","volume":"181","author":"E Borrelli","year":"2017","unstructured":"Borrelli, E. et al. Postreceptor neuronal loss in intermediate age-related macular degeneration. Am. J. Ophthalmol. 181, 1\u201311. https:\/\/doi.org\/10.1016\/j.ajo.2017.06.005 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"85110_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8125267","author":"CA Moreira-Neto","year":"2018","unstructured":"Moreira-Neto, C. A., Moult, E. M., Fujimoto, J. G., Waheed, N. K. & Ferrara, D. Choriocapillaris loss in advanced age-related macular degeneration. J. Ophthalmol.https:\/\/doi.org\/10.1155\/2018\/8125267 (2018).","journal-title":"J. Ophthalmol."},{"key":"85110_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1167\/iovs.18-25325","volume":"60","author":"DB Russakoff","year":"2019","unstructured":"Russakoff, D. B., Lamin, A., Oakley, J. D., Dubis, A. M. & Sivaprasad, S. Deep learning for prediction of amd progression: a pilot study. Invest. Ophthalmol. Vis. Sci. 60, 712\u2013722. https:\/\/doi.org\/10.1167\/iovs.18-25325 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"85110_CR40","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.ophtha.2017.06.032","volume":"124","author":"K Sleiman","year":"2017","unstructured":"Sleiman, K. et al. Optical coherence tomography predictors of risk for progression to non-neovascular atrophic age-related macular degeneration. Ophthalmology 124, 1764\u20131777. https:\/\/doi.org\/10.1016\/j.ophtha.2017.06.032 (2017).","journal-title":"Ophthalmology"},{"key":"85110_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ophtha.2013.07.013","volume":"121","author":"S Farsiu","year":"2014","unstructured":"Farsiu, S. et al. Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology 121, 162\u2013172. https:\/\/doi.org\/10.1016\/j.ophtha.2013.07.013 (2014).","journal-title":"Ophthalmology"},{"key":"85110_CR42","doi-asserted-by":"crossref","unstructured":"Asgari, R. et\u00a0al. Multiclass segmentation as multitask learning for drusen segmentation in retinal optical coherence tomography. In Shen, D. et\u00a0al. (eds.) Medical image computing and computer assisted intervention\u2014MICCAI 2019, Lecture Notes in Computer Science, 192\u2013200, https:\/\/doi.org\/10.1007\/978-3-030-32239-7_22 (Springer International Publishing, 2019).","DOI":"10.1007\/978-3-030-32239-7_22"},{"key":"85110_CR43","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1038\/s41598-020-62329-9","volume":"10","author":"JI Orlando","year":"2020","unstructured":"Orlando, J. I. et al. Automated quantification of photoreceptor alteration in macular disease using optical coherence tomography and deep learning. Sci. Rep. 10, 5619. https:\/\/doi.org\/10.1038\/s41598-020-62329-9 (2020).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85110-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T17:08:47Z","timestamp":1724605727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85110"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85110-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M.W. serves as a consultant to Bayer and Novartis. U.S.E. serves as a consultant to Boehringer Ingelheim, Genentech, Novartis and Roche. All other authors do not have any interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5743"}}